Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: left upper lobe mass major surgical or invasive procedure: flexible bronchoscopy, left thoracotomy, mediastinal lymph node dissection, left pneumonectomy, chest wall reconstruction with -tex dual mesh oropharyngeal videofluoroscopic evaluation laryngoscopy with vocal cord injection with gelfoam oropharyngeal videfluoroscopy history of present illness: mr. is a 67 year-old male with a history of a left lung lesion. after discussion with the patient and review of his preoperative imaging, the patient had undergone mediastinoscopy at an outside center. the mediastinoscopy had been negative, and as such, the patient was deemed to be a surgical candidate. past medical history: dm (diet controlled) cad (ef 56%, norm perfusion), s/p mi, htn, psh: appy, tonsils social history: non-contributory family history: non-contributory physical exam: general: no apparent distress heent: normocephalic, mucus membranes moist neck; supple, no lymphadenopathy card: rrr, normal s1s2 no murmur/gallop or rub resp: decreased breath sounds gi: positive bowel sounds, abdomen soft non-tender/non-distended extr: warm no edema incision: l thoracotomy site clean/dry/intact, with steri-strips neuro: non-focal pertinent results: wbc-4.7 rbc-3.56* hgb-10.2* hct-30.6 plt ct-487* wbc-9.0 rbc-4.60 hgb-12.8* hct-37.5 plt ct-624* glucose-88 urean-20 creat-0.8 na-141 k-3.8 cl-108 hco3-25 04/14/0 glucose-158* urean-19 creat-0.9 na-134 k-6.1* cl-102 hco3-22 chest (pa & lat) frontal and lateral chest radiographs: no significant change is seen compared to prior study. left-sided subclavian central venous line again seen with tip at the cavoatrial junction. surgical clips again seen at the mediastinum. there are persistent postoperative changes consistent with left pneumonectomy, with persistent left hydropneumothorax, similar in appearance compared to prior study. mild blunting of the right costophrenic angle consistent with small pleural effusion is also unchanged. video oropharyngeal swallow oral phase: there is moderate reduction in bolus formation, bolus control, and anterior-to-posterior tongue movement. there was moderate impairment in the base of the tongue retraction. moderate oral residue was noted after the swallow. no premature spillover was seen in the pharynx. pharyngeal phase: the pharyngeal swallow was timely. there is moderate reduction in laryngeal elevation and valve closure. epiglottic deflection was severely reduced. a moderate-to-severe amount of residue remained in the vallecula, and a mild amount of residue remained in the piriform sinuses after the swallow. aspiration/penetration: there was penetration during the swallow with thin liquids via straw sips. aspiration occurred after the swallow with thin- and thick-nectar liquids due to residue falling from the laryngeal vestibule into the airway. aspiration was silent (without coughing). a cued cough was not effective in clearing the aspirated material. impression: 1. aspiration of thin liquids after the swallow with straw sips. 2. cued cough was ineffective in clearing the aspirated material. 3. no aspiration with nectar-thick liquid when swallow-cough-swallow technique was performed. brief hospital course: mr. is who was admitted on and underwent successful left thoracotomy, left pneumonectomy with en bloc chest wall resection (third rib); mediastinal lymph node dissection, flexible bronchoscopy. he was extubated in the operating room and transferred to the sicu for close monitoring. his pain was managed with a dilaudid epidural managed by the acute pain service. he had a pen-rose drain , foley and ng tube in place. on pod #1 he was seen by ent for his vagal resection and found to have a left vocal fold paresis. he was seen by speech and swallow and found to have moderate to severe oropharyngeal dysphagia with aspiration of small amounts of all consistencies. on pod #2 underwent left true vocal fold gelfoam therapeutic injection. on pod #3 he was transfused with 1 unit prbc to a hct of 30, a dobbhoff feeding tube was placed and tube feeds were started per nutrition recommendations. on pod #5 he developed atrial fibrillation with a rvr and was started on iv amiodarone converted to sinus rhythm within 24 hours. on pod #6 he continued to remain hemodynamically stable and transferred to the floor. his epidural was converted to dilaudid pca with good pain control. the foley was removed and he voided without difficulty. on pod #8 a repeat video-swallow was performed and he aspirated with thin liquids. speech recommended ground with nectar thick and supervision feeds which was started and he tolerated. follow-up video-swallow in days. he was seen by physical therapy. he was seen by ent who recommended follow-up in weeks. on pod #10 he was restarted on his home medication and po pain meds. he continued to make steady progress his oxygen saturation remained 93% on room air while ambulating and was discharged to rehab. he will follow-up with dr. , dr. and dr. as an outpatient. medications on admission: allopurinol 300 daily, atenolol 100 daily, lasix 40 daily, lisinopril 40 daily, nifedipine 60 daily discharge medications: 1. bisacodyl 5 mg tablet, delayed release (e.c.) : two (2) tablet, delayed release (e.c.) po daily (daily) as needed. disp:*60 tablet, delayed release (e.c.)(s)* refills:*0* 2. docusate sodium 50 mg/5 ml liquid : ten (10) ml po bid (2 times a day). disp:*60 * refills:*0* 3. insulin sliding scale regular insulin sliding scale 4. prevacid solutab 30 mg tablet,rapid dissolve, dr : one (1) tablet,rapid dissolve, dr once a day. 5. lisinopril 20 mg tablet : one (1) tablet po daily (daily): crush give with puree food. 6. amiodarone 200 mg tablet : two (2) tablet po daily (daily): crush give with puree. 7. hydromorphone 2 mg tablet : 1-2 tablets po q3h (every 3 hours) as needed: crush give with puree. 8. allopurinol 300 mg tablet : one (1) tablet po once a day: crush give with puree. 9. atrovent hfa 17 mcg/actuation aerosol : 1-2 puffs inhalation every 6-8 hours as needed for shortness of breath or wheezing. 10. albuterol 90 mcg/actuation aerosol : 1-2 puffs inhalation every six (6) hours as needed for shortness of breath or wheezing. 11. bisacodyl 5 mg tablet, delayed release (e.c.) : two (2) tablet, delayed release (e.c.) po daily (daily) as needed for constipation. 12. metoprolol tartrate 25 mg tablet : 1.5 tablets po bid (2 times a day): hold hr < 60 sbp < 100 crush & give in puree. discharge disposition: extended care facility: baypointe - discharge diagnosis: left upper lobe squamous cell carcinoma hypertension coronary artery disease s/p mi diabetes mellitus type ii smoker tonsillectomy, appy discharge condition: stable discharge instructions: call dr. office if experince: -temp greater than 101 -increased shortness of breath, cough -chest pain -incision develops drainage or increased redness steri-strips remove in 10 days or sooner if start to peel off -keep head of bed elevated > 30 degress at all times you may shower: no bathing or swimming for 6 weeks follow-up with cardiology for amiodarone dosing. followup instructions: follow up with dr. on at 9:30am on the clinical center report to the radiology department for a chest x-ray 45 minutes before your appointment. follow-up with dr. on 11:45am at , medical building . follow-up with your pcp . follow-up with dr. cardiology in 2 months call for an appointment on the clinical center procedure: venous catheterization, not elsewhere classified parenteral infusion of concentrated nutritional substances fiber-optic bronchoscopy injection or infusion of other therapeutic or prophylactic substance laryngoscopy and other tracheoscopy other repair of chest wall division or crushing of other cranial and peripheral nerves regional lymph node excision transfusion of packed cells insertion of (naso-)intestinal tube excision or destruction of lesion of chest wall injection of larynx other lobectomy of lung diagnoses: anemia, unspecified coronary atherosclerosis of native coronary artery tobacco use disorder unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation secondary malignant neoplasm of other specified sites secondary malignant neoplasm of pleura paroxysmal ventricular tachycardia malignant neoplasm of other parts of bronchus or lung secondary and unspecified malignant neoplasm of intrathoracic lymph nodes bronchitis, not specified as acute or chronic dysphagia, oropharyngeal phase unilateral paralysis of vocal cords or larynx, complete 

Answer: The patient is high likely exposed to